Pharmaceutical Track and Trace

Learn how GS1 Standards can help your company

As the pharmaceutical industry continues its preparations for the Drug Supply Chain Security Act (DSCSA) serialization requirements*, more and more trading partners are focusing on the journey to DSCSA item-level traceability starting in 2023, and many trading partners have already made significant investments in serializing product lines and implementing serialized item traceability systems.

The resources below will help you learn how GS1 Standards can be applied for DSCSA serialization, lot-level management, and item-level traceability to track and trace products at the product and case level.

GS1 Standards for DSCSA Suppliers Certificate Course

Preparing for DSCSA Requirements?

Register for our GS1 Standards for DSCSA Suppliers Certificate Course

Pharma
implementation guide

Implementation Guideline

Release 1.2 of the GS1 US Implementation Guideline for Applying GS1 Standards for DSCSA and Traceability

epcis conformance testing

Frequently Asked Questions

To assist the pharmaceutical industry in implementing GS1 Standards to support the requirements of DSCSA.

DSCSA Barcode Assessment

Implementation of DSCSA Serialization Requirements

Pharmaceutical wholesalers uncover significant progress in barcode assessments

implementation support

Implementation Support

Customized support to help improve operations and enhance quality of care

Resources for Healthcare Providers

Are you a Healthcare Provider and looking for education and implementation resources? If so, please visit www.gs1us.org/HealthcareProviders to learn how GS1 Standards can help your organization modernize its supply chain, improve patient safety, and reduce costs.

*For information about the act, see the 2013 Drug Supply Chain Security Act

Disclaimer: GS1 US is the local GS1 Member Organization that supports implementation of the GS1 System in the United States. GS1 US employees are not representatives or agents of the U.S. FDA, and the content herein has not been reviewed, approved, or authorized by the U.S. FDA.